Anakinra shows promise for hidradenitis suppurativa

The results of a pilot study suggest that the interleukin-1(IL-1) receptor antagonist anakinra may be a potential treatment option for hidradenitis suppurativa (HS).

The cause of HS – a chronic skin...

Field of Interest: Dermatology